236 related articles for article (PubMed ID: 30270167)
1. Health-Related Quality of Life in Children and Young Adults with Marfan Syndrome.
Handisides JC; Hollenbeck-Pringle D; Uzark K; Trachtenberg FL; Pemberton VL; Atz TW; Bradley TJ; Cappella E; De Nobele S; Groh GK; Hamstra MS; Korsin R; Levine JC; Lindauer B; Liou A; Neal MKM; Markham LW; Morrison T; Mussatto KA; Olson AK; Pierpont MEM; Pyeritz RE; Radojewski EA; Roman MJ; Xu M; Lacro RV;
J Pediatr; 2019 Jan; 204():250-255.e1. PubMed ID: 30270167
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Rapid Aortic Root Dilation and Referral for Aortic Surgery in Marfan Syndrome.
Hoskoppal A; Menon S; Trachtenberg F; Burns KM; De Backer J; Gelb BD; Gleason M; James J; Lai WW; Liou A; Mahony L; Olson AK; Pyeritz RE; Sharkey AM; Stylianou M; Wechsler SB; Young L; Levine JC; Tierney ESS; Lacro RV; Bradley TJ;
Pediatr Cardiol; 2018 Oct; 39(7):1453-1461. PubMed ID: 29948025
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of children and young adults with Marfan syndrome and aortic root dilation in a randomized trial comparing atenolol and losartan therapy.
Lacro RV; Guey LT; Dietz HC; Pearson GD; Yetman AT; Gelb BD; Loeys BL; Benson DW; Bradley TJ; De Backer J; Forbus GA; Klein GL; Lai WW; Levine JC; Lewin MB; Markham LW; Paridon SM; Pierpont ME; Radojewski E; Selamet Tierney ES; Sharkey AM; Wechsler SB; Mahony L;
Am Heart J; 2013 May; 165(5):828-835.e3. PubMed ID: 23622922
[TBL] [Abstract][Full Text] [Related]
4. Variants in ADRB1 and CYP2C9: Association with Response to Atenolol and Losartan in Marfan Syndrome.
Van Driest SL; Sleeper LA; Gelb BD; Morris SA; Dietz HC; Forbus GA; Goldmuntz E; Hoskoppal A; James J; Lee TM; Levine JC; Li JS; Loeys BL; Markham LW; Meester JAN; Mital S; Mosley JD; Olson AK; Renard M; Shaffer CM; Sharkey A; Young L; Lacro RV; Roden DM
J Pediatr; 2020 Jul; 222():213-220.e5. PubMed ID: 32586526
[TBL] [Abstract][Full Text] [Related]
5. [Study of the efficacy and safety of losartan versus atenolol for aortic dilation in patients with Marfan syndrome].
Forteza A; Evangelista A; Sánchez V; Teixidó G; García D; Sanz P; Gutiérrez L; Centeno J; Rodríguez-Palomares J; Cortina J; García-Dorado D
Rev Esp Cardiol; 2011 Jun; 64(6):492-8. PubMed ID: 21561700
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in children and adolescents with Marfan syndrome or related disorders: a controlled cross-sectional study.
Edouard T; Picot MC; Bajanca F; Huguet H; Guitarte A; Langeois M; Chesneau B; Van Kien PK; Garrigue E; Dulac Y; Amedro P
Orphanet J Rare Dis; 2024 Apr; 19(1):180. PubMed ID: 38685042
[TBL] [Abstract][Full Text] [Related]
7. Atenolol versus losartan in children and young adults with Marfan's syndrome.
Lacro RV; Dietz HC; Sleeper LA; Yetman AT; Bradley TJ; Colan SD; Pearson GD; Selamet Tierney ES; Levine JC; Atz AM; Benson DW; Braverman AC; Chen S; De Backer J; Gelb BD; Grossfeld PD; Klein GL; Lai WW; Liou A; Loeys BL; Markham LW; Olson AK; Paridon SM; Pemberton VL; Pierpont ME; Pyeritz RE; Radojewski E; Roman MJ; Sharkey AM; Stylianou MP; Wechsler SB; Young LT; Mahony L;
N Engl J Med; 2014 Nov; 371(22):2061-71. PubMed ID: 25405392
[TBL] [Abstract][Full Text] [Related]
8. Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome.
Lacro RV; Dietz HC; Wruck LM; Bradley TJ; Colan SD; Devereux RB; Klein GL; Li JS; Minich LL; Paridon SM; Pearson GD; Printz BF; Pyeritz RE; Radojewski E; Roman MJ; Saul JP; Stylianou MP; Mahony L;
Am Heart J; 2007 Oct; 154(4):624-31. PubMed ID: 17892982
[TBL] [Abstract][Full Text] [Related]
9. Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome.
Teixido-Tura G; Forteza A; Rodríguez-Palomares J; González Mirelis J; Gutiérrez L; Sánchez V; Ibáñez B; García-Dorado D; Evangelista A
J Am Coll Cardiol; 2018 Oct; 72(14):1613-1618. PubMed ID: 30261963
[TBL] [Abstract][Full Text] [Related]
10. Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome.
Bhatt AB; Buck JS; Zuflacht JP; Milian J; Kadivar S; Gauvreau K; Singh MN; Creager MA
Vasc Med; 2015 Aug; 20(4):317-25. PubMed ID: 25795452
[TBL] [Abstract][Full Text] [Related]
11. Recruitment, retention, and adherence in a clinical trial: The Pediatric Heart Network's Marfan Trial experience.
Hamstra MS; Pemberton VL; Dagincourt N; Hollenbeck-Pringle D; Trachtenberg FL; Cnota JF; Atz AM; Cappella E; De Nobele S; Grima J; King M; Korsin R; Lambert LM; MacNeal MK; Markham LW; MacCarrick G; Sylvester DM; Walter P; Xu M; Lacro RV;
Clin Trials; 2020 Dec; 17(6):684-695. PubMed ID: 32820647
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial.
Forteza A; Evangelista A; Sánchez V; Teixidó-Turà G; Sanz P; Gutiérrez L; Gracia T; Centeno J; Rodríguez-Palomares J; Rufilanchas JJ; Cortina J; Ferreira-González I; García-Dorado D
Eur Heart J; 2016 Mar; 37(12):978-85. PubMed ID: 26518245
[TBL] [Abstract][Full Text] [Related]
13. Racial and ethnic differences in response to treatment for Marfan syndrome.
Ayers R; Kelleman M; Iannucci G; McCracken C; Oster ME
Cardiol Young; 2021 Dec; 31(12):1991-1998. PubMed ID: 33845931
[TBL] [Abstract][Full Text] [Related]
14. Influence of Aortic Stiffness on Aortic-Root Growth Rate and Outcome in Patients With the Marfan Syndrome.
Selamet Tierney ES; Levine JC; Sleeper LA; Roman MJ; Bradley TJ; Colan SD; Chen S; Campbell MJ; Cohen MS; De Backer J; Heydarian H; Hoskoppal A; Lai WW; Liou A; Marcus E; Nutting A; Olson AK; Parra DA; Pearson GD; Pierpont ME; Printz BF; Pyeritz RE; Ravekes W; Sharkey AM; Srivastava S; Young L; Lacro RV;
Am J Cardiol; 2018 May; 121(9):1094-1101. PubMed ID: 29631804
[TBL] [Abstract][Full Text] [Related]
15. Association of Persistent Postconcussion Symptoms With Pediatric Quality of Life.
Novak Z; Aglipay M; Barrowman N; Yeates KO; Beauchamp MH; Gravel J; Freedman SB; Gagnon I; Gioia G; Boutis K; Burns E; Ledoux AA; Osmond MH; Zemek RL;
JAMA Pediatr; 2016 Dec; 170(12):e162900. PubMed ID: 27775762
[TBL] [Abstract][Full Text] [Related]
16. Measurement of health-related quality of life in children undergoing external fixator treatment for lower limb deformities.
Montpetit K; Hamdy RC; Dahan-Oliel N; Zhang X; Narayanan UG
J Pediatr Orthop; 2009 Dec; 29(8):920-6. PubMed ID: 19934710
[TBL] [Abstract][Full Text] [Related]
17. Use of the Pediatric Quality of Life Inventory to assess the health-related quality of life in children with recurrent respiratory papillomatosis.
Lindman JP; Lewis LS; Accortt N; Wiatrak BJ
Ann Otol Rhinol Laryngol; 2005 Jul; 114(7):499-503. PubMed ID: 16134343
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life in pediatric Chiari Type I malformation: the Chiari Health Index for Pediatrics.
Ladner TR; Westrick AC; Wellons JC; Shannon CN
J Neurosurg Pediatr; 2016 Jan; 17(1):76-85. PubMed ID: 26431245
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life of children with attention-deficit/hyperactivity disorder versus children with diabetes and healthy controls.
Coghill D; Hodgkins P
Eur Child Adolesc Psychiatry; 2016 Mar; 25(3):261-71. PubMed ID: 26054300
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
